Neuropsychological Issues and Outcome in Covid-19 Adult and Pediatric Patients

Tuesday, November 9, 2021
4:30 PM - 6:00 PM ET
1.5 CE Credits 

Presented by: 
Douglas Whiteside, PhD, ABPP /CN

Professor of Rehabilitation Medicine
University of Minnesota, Division of Neuropsychology
Department of Rehabilitation Medicine

Christine Hajek Koterba, Ph.D., ABPP

Pediatric Neuropsychologist
Department of Pediatric Psychology and Neuropsychology 
Nationwide Children's Hospital
Columbus, Ohio

COVID-19 is perhaps the most serious public health crisis in decades due to the widespread impact on society and individuals. This presentation will examine the common issues neuropsychologists face when evaluating adult and pediatric patients who have been directly and indirectly impacted by COVID-19. Preliminary research in adults suggests some trends in terms of understanding cognitive and psychiatric outcomes, and comparisons to other patient populations such as post-concussion syndrome (PCS) in adults may be illustrative. Initial group data and case studies illustrate common issues seen in adults with long-term COVID-19 complaints, or post-acute sequelae of SARS CoV-2 infection (PASC). In children, the impact of COVID-19 may be less direct. Factors such as inconsistent or limited access to educational instruction, limited opportunities for socialization, and reduced special education support have had a profound impact on many children. Presenters will discuss how these factors may influence neuropsychological testing, diagnostic impressions, and recommendations for management.

At the end of this webinar, participants will be able to: 
1. Describe common cognitive and emotional concerns of severe and long COVID patients.
2. Compare PASC patients with similar patients from PCS and psychiatric groups such as those with depression.
3. List challenges associated with neuropsychological assessment of learning disorders in children during the COVID-19 pandemic. 
4. Discuss ways the COVID-19 pandemic has impacted children’s academic functioning and mental health. 

Target Audience: Neuropsychologists, students, interns, and postdoctoral fellows who work clinically with post-Covid-19 patients.
Instruction Level: Intermediate

Doug Whiteside is a board-certified clinical neuropsychologist and Professor of Rehabilitation Medicine at the University of Minnesota where he is the Director of Training for the Neuropsychology Division’s Postdoctoral Residency Program. He is currently President of the Association of Postdoctoral Programs in Clinical Neuropsychology (APPCN) and is an Associate Editor for The Clinical Neuropsychologist. He earned his PhD from the University of Nebraska-Lincoln after completing internship at the Ann Arbor VA Medical Center, and he completed postdoctoral training in neuropsychology at the Albuquerque VA Medical Center. He is actively involved in clinical neuropsychological practice, teaching, research, and community service. His research interests focus primarily on performance validity tests, personality assessment measures in neuropsychological assessment, and long term cognitive and emotional outcome of COVID-19 infection.

Christine H. Koterba, PhD,
is a Pediatric Neuropsychologist at Nationwide Children's Hospital and a Clinical Assistant Professor of Pediatrics at The Ohio State University. She is the attending neuropsychologist on the Nationwide Children's Inpatient Rehabilitation Unit and is involved in the pre- and post-doctoral neuropsychological training programs. Her clinical interests include Pediatric Neuropsychology, Traumatic and Acquired Brain Injury, Rehabilitation Psychology and Spina Bifida Myelomeningocele. Her research interests include psychological and neuropsychological outcomes in pediatric traumatic and acquired brain injury.

NAN members login and non-members create an account to: